Canadian Watchdog Reaches Agreement To Preserve Competition In Paper Industry

The Competition Bureau announced that it has reached an agreement to address competition concerns with the merger of two of Canada’s largest pulp and paper manufacturers – Karta Halten B.V. and Domtar.
A Bureau review concluded that the proposed transaction would likely lessen competition substantially for the purchase of wood fibre – a key input in the manufacture of pulp – from the Thompson/Okanagan region of British Columbia.
The Bureau determined that the proposed transaction is anti-competitive because it would provide Paper Excellence with monopsony power in a large part of southern British Columbia. This would enable Paper Excellence to pay lower than competitive prices to sawmills and other suppliers of wood fibre in a region of British Columbia where Paper Excellence already has a high concentration of pulp mills.
To resolve the Bureau’s concerns, Paper Excellence has agreed to sell Domtar’s pulp mill in Kamloops, BC, following its acquisition. The sale will be made to an independent purchaser to be approved by the Commissioner of Competition.
The Commissioner is satisfied that the sale of the Kamloops mill will resolve the competitive issues arising from the proposed transaction. The complete agreement is available on the website of the Competition Tribunal.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas